Form 4: Credo CFO Sells Shares Under 10b5-1 Plan

Credo Technology Group's CFO, Daniel W. Fleming, sold 8,562 ordinary shares for approximately $1.14 million through a pre-arranged Rule 10b5-1 trading plan.

Summary

• Daniel W. Fleming, Chief Financial Officer of Credo Technology Group Holding Ltd (CRDO), sold a total of 8,562 ordinary shares.
• The sales were executed on January 7, 2026, and January 8, 2026.
• On January 7, 2026, 4,136 shares were sold at a weighted average price of $128.0977 per share.
• Also on January 7, 2026, an additional 524 shares were sold at a weighted average price of $128.9892 per share.
• On January 8, 2026, 3,902 shares were sold at a weighted average price of $140.1505 per share.
• These transactions were conducted pursuant to a Rule 10b5-1 trading plan adopted by Mr. Fleming on June 19, 2025.
• Following these transactions, Mr. Fleming beneficially owns 446,178 ordinary shares directly.

Sentiment

Score: 5

Explanation: The sentiment is neutral. While an insider sale can be perceived negatively, the execution under a Rule 10b5-1 plan mitigates concerns about opportunistic selling, making it a routine personal financial management event.

Positives

• The sales were conducted under a pre-arranged Rule 10b5-1 trading plan, indicating a planned divestment rather than a reaction to new, undisclosed negative information.

Negatives

• An insider sale, even if pre-planned, reduces the insider's direct equity stake in the company.
• The sale of shares by a Chief Financial Officer could be interpreted by some investors as a reduction in insider confidence, despite the 10b5-1 plan.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance.

Industry Context

This insider transaction is a routine disclosure for a publicly traded company and does not inherently reflect broader industry trends or competitive dynamics. It is specific to the individual's personal financial planning.

Comparison to Industry Standards

• This filing details an insider stock sale, which is a common occurrence across all industries for executives managing personal finances.
• The use of a Rule 10b5-1 plan is a standard practice for insiders to sell shares in a pre-arranged, compliant manner, mitigating concerns about trading on material non-public information.
• No specific comparable companies or projects are relevant for this type of individual transaction.

Stakeholder Impact

• Shareholders: May interpret the sale as a slight negative signal, though the 10b5-1 plan reduces this impact. The reduction in insider ownership is minimal relative to total shares outstanding.
• Employees, Customers, Suppliers, Creditors: No direct impact from this insider transaction.

Key Dates

Recommendation

This Form 4 filing reports a routine insider sale executed under a pre-arranged Rule 10b5-1 trading plan. Such transactions are typically for personal financial management and do not usually signal a change in the company's fundamental outlook or warrant a change in investment recommendation based solely on this filing. Investors should continue to evaluate CRDO based on its operational performance, financial results, and strategic initiatives.

Keywords

Credo Technology Group, CRDO, Form 4, Insider Sale, Daniel W. Fleming, CFO, 10b5-1 Plan, Equity Transaction, Share Sale